These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 9462649)
1. Involvement of intrasinusoidal hemostasis in the development of concanavalin A-induced hepatic injury in mice. Miyazawa Y; Tsutsui H; Mizuhara H; Fujiwara H; Kaneda K Hepatology; 1998 Feb; 27(2):497-506. PubMed ID: 9462649 [TBL] [Abstract][Full Text] [Related]
2. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice. Mizuhara H; Kuno M; Seki N; Yu WG; Yamaoka M; Yamashita M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H Hepatology; 1998 Feb; 27(2):513-9. PubMed ID: 9462651 [TBL] [Abstract][Full Text] [Related]
3. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184 [TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production. Ishizaki K; Iwaki T; Kinoshita S; Koyama M; Fukunari A; Tanaka H; Tsurufuji M; Sakata K; Maeda Y; Imada T; Chiba K Eur J Pharmacol; 2008 Jan; 578(1):57-64. PubMed ID: 17888421 [TBL] [Abstract][Full Text] [Related]
5. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Küsters S; Gantner F; Künstle G; Tiegs G Gastroenterology; 1996 Aug; 111(2):462-71. PubMed ID: 8690213 [TBL] [Abstract][Full Text] [Related]
6. Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A. Kimura K; Ando K; Ohnishi H; Ishikawa T; Kakumu S; Takemura M; Muto Y; Moriwaki H Int Immunol; 1999 Sep; 11(9):1491-500. PubMed ID: 10464170 [TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice. Kato J; Okamoto T; Motoyama H; Uchiyama R; Kirchhofer D; Van Rooijen N; Enomoto H; Nishiguchi S; Kawada N; Fujimoto J; Tsutsui H Hepatology; 2013 Jan; 57(1):362-72. PubMed ID: 22936459 [TBL] [Abstract][Full Text] [Related]
8. Concanavalin-A-induced liver injury is severely impaired in mice deficient in P-selectin. Massaguer A; Perez-Del-Pulgar S; Engel P; Serratosa J; Bosch J; Pizcueta P J Leukoc Biol; 2002 Aug; 72(2):262-70. PubMed ID: 12149416 [TBL] [Abstract][Full Text] [Related]
10. A selective adenosine A2A receptor agonist, ATL-146e, prevents concanavalin A-induced acute liver injury in mice. Odashima M; Otaka M; Jin M; Horikawa Y; Matsuhashi T; Ohba R; Linden J; Watanabe S Biochem Biophys Res Commun; 2006 Sep; 347(4):949-54. PubMed ID: 16859640 [TBL] [Abstract][Full Text] [Related]
11. Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury. Watanabe Y; Morita M; Akaike T Hepatology; 1996 Sep; 24(3):702-10. PubMed ID: 8781346 [TBL] [Abstract][Full Text] [Related]
12. Experimental hepatitis and role of cytokines. Tiegs G Acta Gastroenterol Belg; 1997; 60(2):176-9. PubMed ID: 9260332 [TBL] [Abstract][Full Text] [Related]
13. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. Mizuhara H; O'Neill E; Seki N; Ogawa T; Kusunoki C; Otsuka K; Satoh S; Niwa M; Senoh H; Fujiwara H J Exp Med; 1994 May; 179(5):1529-37. PubMed ID: 8163936 [TBL] [Abstract][Full Text] [Related]
14. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury. Wang J; Sun R; Wei H; Dong Z; Tian Z Int Immunopharmacol; 2006 May; 6(5):800-7. PubMed ID: 16546711 [TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3 facilitates con a-induced IFN-γ-- mediated immune hepatic injury. Tsai CC; Huang WC; Chen CL; Hsieh CY; Lin YS; Chen SH; Yang KC; Lin CF J Immunol; 2011 Oct; 187(7):3867-77. PubMed ID: 21873526 [TBL] [Abstract][Full Text] [Related]
17. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. Tiegs G; Hentschel J; Wendel A J Clin Invest; 1992 Jul; 90(1):196-203. PubMed ID: 1634608 [TBL] [Abstract][Full Text] [Related]
18. 1-Methylnicotinamide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α. Jakubowski A; Sternak M; Jablonski K; Ciszek-Lenda M; Marcinkiewicz J; Chlopicki S Int Immunopharmacol; 2016 Feb; 31():98-104. PubMed ID: 26709075 [TBL] [Abstract][Full Text] [Related]
19. Possible changes in expression of chemotaxin LECT2 mRNA in mouse liver after concanavalin A-induced hepatic injury. Segawa Y; Itokazu Y; Inoue N; Saito T; Suzuki K Biol Pharm Bull; 2001 Apr; 24(4):425-8. PubMed ID: 11305608 [TBL] [Abstract][Full Text] [Related]
20. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. Toyabe S; Seki S; Iiai T; Takeda K; Shirai K; Watanabe H; Hiraide H; Uchiyama M; Abo T J Immunol; 1997 Aug; 159(3):1537-42. PubMed ID: 9233653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]